Cargando…

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Proton pump inhibitors (PPI) are an invaluable therapy option for acid related diseases; however, PPI therapy is also linked to a series of side effects in cirrhosis, such as microbiome alterations, spontaneous bacterial peritonitis and hepatic encephalopathy. Decision tools to balance benefits and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horvath, Angela, Rainer, Florian, Bashir, Mina, Leber, Bettina, Schmerboeck, Bianca, Klymiuk, Ingeborg, Groselj-Strele, Andrea, Durdevic, Marija, Freedberg, Daniel E., Abrams, Julian A., Fickert, Peter, Stiegler, Philipp, Stadlbauer, Vanessa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700098/ https://www.ncbi.nlm.nih.gov/pubmed/31427714 http://dx.doi.org/10.1038/s41598-019-48352-5

Ejemplares similares

Disease severity and proton pump inhibitor use impact strongest on faecal microbiome composition in liver cirrhosis
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers
por: Stadlbauer, Vanessa, et al.
Publicado: (2019)

Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2020)

Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis
por: Horvath, A., et al.
Publicado: (2016)

Lactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study
por: Stadlbauer, Vanessa, et al.
Publicado: (2015)

The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study
por: Horvath, Angela, et al.
Publicado: (2020)

Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis
por: Stadlbauer, Vanessa, et al.
Publicado: (2017)

Author Correction: Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis
por: Stadlbauer, Vanessa, et al.
Publicado: (2019)

Serum bile acids in liver cirrhosis promote neutrophil dysfunction
por: Balazs, Irina, et al.
Publicado: (2022)

Celiac disease serology and gut microbiome following proton pump inhibitor treatment
por: Jang, Sophie, et al.
Publicado: (2020)

Safe use of proton pump inhibitors in patients with cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Secondary Sclerosing Cholangitis in Critically Ill Patients Alters the Gut–Liver Axis: A Case Control Study
por: Blesl, Andreas, et al.
Publicado: (2020)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

NMR spectroscopy enables simultaneous quantification of carbohydrates for diagnosis of intestinal and gastric permeability
por: Stryeck, Sarah, et al.
Publicado: (2018)

Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study
por: Lindheim, Lisa, et al.
Publicado: (2017)

Validation of Malnutrition Screening Tools in Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2020)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes
por: Spindelboeck, Walter, et al.
Publicado: (2016)

A novel score predicts mortality after transjugular intrahepatic portosystemic shunt: MOTS ‐ Modified TIPS Score
por: Fürschuß, Luisa, et al.
Publicado: (2022)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies
por: Wu, Xiaoli, et al.
Publicado: (2020)

Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2023)

Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
por: Sturm, Lukas, et al.
Publicado: (2023)

Probiotic Supplementation Suppresses Tumor Growth in an Experimental Colorectal Cancer Liver Metastasis Model
por: Jakubauskas, Matas, et al.
Publicado: (2022)

Probiotic Supplementation Attenuates Chemotherapy-Induced Intestinal Mucositis in an Experimental Colorectal Cancer Liver Metastasis Rat Model
por: Jakubauskas, Matas, et al.
Publicado: (2023)

Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study
por: Horvath, Angela, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
por: Yasugi, Kengo, et al.
Publicado: (2021)

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
por: Zhang, Pan, et al.
Publicado: (2022)

Functional Electrical Stimulation for Presbyphonia: A Prospective Randomized Trial
por: Gugatschka, Markus, et al.
Publicado: (2020)

Application of a multispecies probiotic reduces gastro-intestinal discomfort and induces microbial changes after colonoscopy
por: Labenz, Joachim, et al.
Publicado: (2023)

Circulating neutrophil anti-pathogen dysfunction in cirrhosis
por: Balazs, Irina, et al.
Publicado: (2023)

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
por: Suppan, Christoph, et al.
Publicado: (2015)

Malnutrition in Patients with Liver Cirrhosis
por: Traub, Julia, et al.
Publicado: (2021)

Impact of Melatonin in Solid Organ Transplantation—Is It Time for Clinical Trials? A Comprehensive Review
por: Stiegler, Philipp, et al.
Publicado: (2018)

Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects
por: Kvietkauskas, Mindaugas, et al.
Publicado: (2020)

Combating Ischemia-Reperfusion Injury with Micronutrients and Natural Compounds during Solid Organ Transplantation: Data of Clinical Trials and Lessons of Preclinical Findings
por: Mauerhofer, Christina, et al.
Publicado: (2021)

Oral Intake of L-Ornithine-L-Aspartate Is Associated with Distinct Microbiome and Metabolome Changes in Cirrhosis
por: Horvath, Angela, et al.
Publicado: (2022)

Bacterial load and cytokine profile in patients with cirrhosis following therapy with proton pump inhibitors: a prospective cohort study
por: Triantos, Christos, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u3iu13ve3t28o44ca72rgag07c